)
Visual
test
Embecta
Embecta (EMBC) investor relations material
Embecta Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy Filing summary23 Jan, 2026
Voting matters and shareholder proposals
Proposal 4 seeks approval to amend the 2022 Employee and Director Equity-Based Compensation Plan, increasing available shares by 2,430,000, as approved by the Board on December 2, 2025.
Institutional Shareholder Services (ISS) recommended voting against the amendment, citing that the stockholder value transfer (SVT) exceeded ISS benchmarks based on a September 30, 2025 calculation date.
The company argues that using a November 30, 2025 calculation date aligns the plan with ISS guidelines and provides updated share activity data to support this.
The Board maintains its recommendation to vote in favor of Proposal 4.
Executive compensation and say-on-pay
The amendment to the 2022 Plan is intended to ensure sufficient equity incentives for employees and directors, with updated figures on outstanding awards and share reserves.
Outstanding performance share units (PSUs) include awards with targets to be established in the future, reflecting ongoing performance-based compensation practices.
Board of directors and corporate governance
The Board approved the proposed amendment to the equity plan on December 2, 2025, demonstrating active oversight of compensation policies.
Explain the ISS SVT calculation discrepancy
What is the total share reserve after amendment?
Clarify PSU awards with unestablished targets
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7988
Slight sales dip, profit growth, and higher dividends forecast for FY2025. - KESKOB
Profit and revenue rose in all divisions in 2025, with a positive outlook for 2026. - 8058
Strong cash flow and earnings progress, despite revenue decline and major affiliate changes. - KESKOBProfit and sales rose in all divisions, with strong market share gains and positive 2026 outlook.
- 4901
Record revenue and profit guidance upgrades driven by Electronics and Imaging growth. - AKTIA
Strong Q4 income, life insurance growth, Taaleri impairment, and CET1 ratio up to 12.6%. - NCC
Record profits in core segments offset by major impairment; dividend maintained, outlook positive. - HTRO
Q4 2025 saw 10% organic sales growth, but restructuring costs led to a net loss. - SHL
Q1 FY2026 saw 3.8% revenue growth, strong Imaging, and confirmed FY2026 outlook. - REDINGTON
Record revenue and profit, strong SSG and SISA growth, but margin pressure in TSG and Arena.
Next Embecta earnings date
Q1 20265 Feb, 2026
Embecta
Next Embecta earnings date
Q1 20265 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Embecta Corp is a medical technology company focused on the development and manufacturing of diabetes care products. The company specializes in providing devices and solutions for insulin delivery, including insulin syringes and pen needles, aimed at improving the daily management of diabetes. Embecta serves healthcare providers and patients globally, with a mission to support individuals with diabetes in maintaining their health through reliable and accessible products. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage